Elanco Animal Health Inc

5EA.DE | Healthcare | XETRA
$20.35
-0.22 (-1.05%)

Key Metrics

Market Cap
$10.11B
P/E Ratio
339.08
EPS
$0.06
Beta
N/A
Dividend Yield
N/A
ROE
-3.51%
Current Ratio
2.17

Company Information

Industry
Medical Pharmaceuticals

About Elanco Animal Health Inc

Elanco Animal Health Inc engages in the innovation development manufacture and market products for companion and food animals The company is headquartered in Greenfield Indiana and currently employs 5590 fulltime employees The firm offers its products under four primary categories such as Companion Animal Disease Prevention Companion Animal Therapeutics Food Animal Future Protein Health and Food Animal Ruminants Swine The company provides a range of parasiticide portfolios in the companion animal sector based on indications species and formulations with products that protect pets from worms fleas and ticks The company also offers a pain and osteoarthritis portfolio across species modes of action indications and disease stages The company also provides treatments for otitis ear infections as well as cardiovascular and dermatology indications Its portfolio in Food Animal Future Protein Health category includes vaccines nutritional enzymes and animalonly antibiotics The company also provides products in poultry and aquaculture production

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-02-24 $0.11 $0.10 +14.6%
2025-11-05 $0.16 $0.11 +46.1%
2025-08-07 $0.22 $0.17 +30.8%

Financial Ratios (TTM)

Gross Margin
46.20%
Operating Margin
8.06%
Net Margin
-4.92%
ROA
-1.74%
Price to Book
1.81
Price to Sales
2.52